Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 1, 2004, Pages 20-26

  Tanner, Felix C ^a   Largiadèr, Thomas ^b   Greutert, Helen ^a   Yang, Zhihong ^c   Lüscher, Thomas F ^b,d  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; BIOLOGICAL RESPONSE MODIFIER; DIETHYLENETRIAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; GENE; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN; STAINING; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; VASCULAR SMOOTH MUSCLE; VENOUS BYPASS GRAFT DISEASE; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0742305731     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.07.021     Document Type: Article

References (30)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-74.
2. Lawrie GM, Morris GC Jr, Earle N. Long-term results of coronary bypass surgery. Ann Surg. 1991;213:377-87.
3. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
4. Chesebro JH, Clements I, Fuster V, Elveback LR, Smith HC, Bardsley WT, et al. A platelet-inhibitor drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med. 1982;307:73-8.
5. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248-58.
6. Bulkley BH, Hutchins GM. Accelerated atherosclerosis: a morphological study in 97 saphenous vein grafts. Circulation. 1977;55:163-9.
7. Lüscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, et al. Difference between endothelium-dependent relaxations in arterial and in venous coronary bypass grafts. N Engl J Med. 1988;319:462-7.
8. Dattilo JB, Dattilo MP, Spratt JA, Matsuura J, Yager DR, Makhoul RG. Inducible nitric oxide synthase expression in human vein grafts. Am J Surg. 1997;174:177-80.
9. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton (FL): CRC Press; 1990.
10. Ohno T, Gordon D, San H, Pompolij VJ, Imperiale MJ, Nabel GJ, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 1994;265:781-4.
11. Alcorn JL, Gao E, Chen Q, Smith ME, Gerard RD, Mendelson CR. Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene. Mol Endocrinol. 1993;7:1072-85.
12. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol. 1996;70:7498-509.
13. Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Lüscher TF. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase and cyclin-dependent kinase inhibitors. Circulation. 1998;97:181-7.
14. Tanner FC, Meyer P, Greutert H, Champion C, Nabel EG, Lüscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibiting human vascular smooth muscle cell proliferation. Circulation. 2000;101:1982-9.
15. Tsui JC, Souza DS, Filbey D, Karlsson MG, Dashwood MR. Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel 'no-touch' technique: potential role of nitric oxide contribution to improved early graft patency rates. J Vasc Surg. 2002;35:356-62.
16. Tanner FC, Carr DP, Nabel GJ, Nabel EG. Transfection of human endothelial cells. Cardiovasc Res. 1997;35:522-8.
17. Koyama N. Secretion of a potent new migration factor for smooth muscle cells (SMC) by cultured SMC. Atherosclerosis. 1991;86:219-26.
18. Diez-Juan A, Andres V. Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts. Circ Res. 2003;92:402-10.
19. Berndt MC, Phillips DR. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem. 1981;256:59-65.
20. Tanner FC, Yang Z, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res. 1998;82:396-403.
21. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest. 1996;98:899-905.
22. Cable DG, O'Brien T, Schaff HV, Pompili VJ. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits. Circulation. 1997;96(9 suppl):II173-8.
23. Cable DG, Caccitolo JA, Caplice N, O'Brien T, Simari RD, Daly RC, et al. The role of gene therapy for intimal hyperplasia of bypass grafts. Circulation. 1999;100(9 suppl):II392-6.
24. Yu H, Kumar SR, Tang L, Terramani TT, Rowe VL, Wang Y, et al. Injury induced neointima formation and its inhibition by retrovirus-mediated transfer of nitric oxide synthase gene in an in-vitro human saphenous vein culture model. Atherosclerosis. 2002;161:113-22.
25. Uni KK, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol. 1974;34:526-32.
26. Fuster V, Dewanjee MK, Kaye MP, Josa M, Metke MP, Chesebro JH. Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibition. Circulation. 1979;60:1508-12.
27. Pfisterer M, Burkart F, Jockers G, Meyer B, Regenass S, Burckhardt D, et al. Trial of low-dose aspirin plus dipyridamole vs. anticoagulants for prevention of aortocoronary vein graft occlusion. Lancet. 1989;2:1-7.
28. Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-8.
29. Chen L, Theroux P, Lesperance J, Shabani F, Thibault B, De Guise P. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol. 1996;28:1493-9.
30. Gurjar MV, Sharma RV, Bhalla RC. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol. 1999;19:2871-7.